Quality Care
The AI model still has a modest prediction accuracy and is slated for a wider clinical trial soon.
It will use its fresh funds to complete a multi-site validation study across eight Asia-Pacific markets.
This comes after it launched its CDI tool called DxPrime in June.
A review of studies published in npj Digital Medicine found diagnostic and triage accuracy varied but was generally low, raising concerns about using symptom checkers as patient-facing tools.
Dozee's sensor-based technology uses AI to track vital parameters.
Formerly known as IDx, the company received FDA De Novo clearance in 2018 for its IDx-DR system used to detect diabetic retinopathy.
Also, Northwestern University spinout Sibel Health raises $33 million, and real-world evidence startup Atropos Health scoops up $14 million.
It measures the cortical thickness in a brain scan to provide a patient's level of brain ageing.
Ramakant Vempati, Wysa cofounder and president, discusses how the startup tests its AI-backed chatbot to monitor safety and quality.
Also, US-based healthcare cloud solutions provider Healthcare Triangle has expanded to Asia-Pacific.